Inhibitory effects of benzyl benzoate and its derivatives on angiotensin II-induced hypertension

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 16, 2008, Pages 7843-7852

  Ohno, Osamu ^a   Ye, Mao ^b   Koyama, Tomoyuki ^b   Yazawa, Kazunaga ^b   Mura, Emi ^a   Matsumoto, Hiroshi ^a   Ichino, Takao ^a   Yamada, Kaoru ^a   Nakamura, Kazuhiko ^a   Ohno, Tomohiro ^c   Yamaguchi, Kohji ^c   Ishida, Junji ^d   Fukamizu, Akiyoshi ^d   Uemura, Daisuke ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF MARINE SCIENCE AND TECHNOLOGY   (Japan)

^c Central Research Development Laboratory Fancl Corporation   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Angiotensin II; Benzyl benzoate; Benzyl cinnamate; Hypertension; Liquidambar styraciflua; Losartan

Indexed keywords

3 METHYLBENZYL 2' NITROBENZOATE DERIVATIVE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BENZYL BENZOATE; CINNAMIC ACID BENZYL ESTER; LIQUIDAMBAR STYRACIFLUA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG INHIBITION; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYPERTENSION; ISOTOPE LABELING; LIQUIDAMBAR STYRACIFLUA; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZOATES; BENZYL COMPOUNDS; BLOOD PRESSURE; CALCIUM; CELL SURVIVAL; CHO CELLS; CINNAMATES; CRICETINAE; CRICETULUS; HELA CELLS; HUMANS; HYPERTENSION; LIQUIDAMBAR; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; RECEPTOR, ANGIOTENSIN, TYPE 1; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

LIQUIDAMBAR STYRACIFLUA; MUS;

EID: 49149084940     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.03.056     Document Type: Article

References (26)

1. Burnier M., and Brunner H.R. J. Am. Soc. Nephrol. 10 (1999) S278
2. Gavras H., Brunner H.R., Turini G.A., Kershaw G.R., Tifft C.P., Cuttelod S., Gavras I., Vukovich R.A., and McKinstry D.N. N. Engl. J. Med. 298 (1978) 991
3. Corvol P. Clin. Exp. Hypertens. A 11 (1989) 463
4. Brunner H.R., Nussberger J., and Waeber B. Adv. Nephrol. Necker. Hosp. 22 (1993) 305
5. Goodfriend T.L., Elliott M.E., and Catt K.J. N. Engl. J. Med. 334 (1996) 1649
6. Whitebread S., Mele M., Kamber B., and de Gasparo M. Biochem. Biophys. Res. Commun. 163 (1989) 284
7. Wu X., Wan Y., Mahalingam A.K., Murugaiah A.M., Plouffe B., Botros M., Karlén A., Hallberg M., Gallo-Payet N., and Alterman M. J. Med. Chem. 49 (2006) 7160
8. Basso N., and Terragno N.A. Hypertension 38 (2001) 1246
9. Singh R.K., and Barker S. Curr. Opin. Invest. Drugs 6 (2005) 269
10. Mancia G., Seravalle G., and Grassi G. Am. J. Hypertens. 16 (2003) 1066
11. Adang A., Hermkens P., Linders J., Ottenheijm H., and Staveren C. J. R. Neth. Chem. Soc. 113 (1994) 63
12. Carini D.J., Duncia J.V., Johnson A.L., Chiu A.T., Price W.A., Wong P.C., and Timmermans P.B. J. Med. Chem. 33 (1990) 1330
13. Duncia J.V., Carini D.J., Chiu A.T., Johnson A.L., Price W.A., Wong P.C., Wexler R.R., and Timmermans P.B. Med. Res. Rev. 12 (1992) 149
14. Matsoukas J.M., Agelis G., Wahhab A., Hondrelis J., Panagiotopoulos D., Yamdagni R., Wu Q., Mavromoustakos T., Maia H.L., Ganter R., and Moore G.J. J. Med. Chem. 38 (1995) 4660
15. Matsoukas J.M., Polevaya L., Ancans J., Mavromoustakos T., Kolocouris A., Roumelioti P., Vlahakos D.V., Yamdagni R., Wu Q., and Moore G.J. Bioorg. Med. Chem. 8 (2000) 1
16. McClellan K.J., and Goa K.L. Drugs 56 (1998) 847
17. McClellan K.J., and Balfour J.A. Drugs 55 (1998) 713
18. Markham A., Spencer C.M., and Jarvis B. Drugs 59 (2000) 1187
19. Goa K.L., and Wagstaff A.J. Drugs 51 (1996) 820
20. Moutevelis-Minakakis P., Gianni M., Stougiannou H., Zoumpoulakis P., Zoga A., Vlahakos A.D., Iliodromitis E., and Mavromoustakos T. Bioorg. Med. Chem. Lett. 13 (2003) 1737
21. Mavromoustakos T., Moutevelis-Minakakis P., Kokotos C.G., Kontogianni P., Politi A., Zoumpoulakis P., Findlay J., Cox A., Balmforth A., Zoga A., and Iliodromitis E. Bioorg. Med. Chem. 14 (2006) 4353
22. Ismail M.A., Barker S., Abou el-Ella D.A., Abouzid K.A., Toubar R.A., and Todd M.H. J. Med. Chem. 49 (2006) 1526
23. Ishida J., Asada S., Daitoku H., Fujiwara K., Kon Y., Sugaya T., Murakami K., Nakajima T., Kasuya Y., and Fukamizu A. Int. J. Mol. Med. 3 (1999) 263
24. Grynkiewicz G., Poenie M., and Tsien R.Y. J. Biol. Chem. 260 (1985) 3440
25. Webb M.L., Liu E.C., Monshizadegan H., Hedberg A., Misra R.N., Goldenberg H., and Harris D.N. J. Pharmacol. Exp. Ther. 264 (1993) 1387
26. Whitebread S.E., Taylor V., Bottari S.P., Kamber B., and de Gasparo M. Biochem. Biophys. Res. Commun. 181 (1991) 1365